Decreased red cell uroporphyrinogen I synthetase activity in intermittent acute porphyria.
Intermittent acute porphyria has recently been distinguished biochemically from other genetic hepatic porphyrias by the observation of diminished hepatic uroporphyrinogen I synthetase activity and increased delta-aminolevulinic acid synthetase activity. Since deficient uroporphyrinogen I synthetase may be reflected in nonhepatic tissues, we have assayed this enzyme in red cell hemolysates from nonporphyric subjects and from patients with genetic hepatic porphyria. Only patients with intermittent acute porphyria had decreased erythrocyte uroporphyrinogen I synthetase activity which was approximately 50% of normal. The apparent K(m) of partially purified uroporphyrinogen I synthetase was 6 x 10(-6)m in both nonporphyrics and patients with intermittent acute porphyria. These data provide further evidence for a primary mutation affecting uroporphyrinogen I synthetase in intermittent acute porphyria. Further-more, results of assay of red cell uroporphyrinogen I synthetase activity in a large family with intermittent acute porphyria suggest that this test may be a reliable indicator of the heterozygous state.
D000208:Acute Disease; D002848:Chromatography, DEAE-Cellulose; D002850:Chromatography, Gel; D002855:Chromatography, Thin Layer; D004912:Erythrocytes / Q000201:enzymology*; D005260:Female; D006579:Heterozygote; D006801:Humans; D007700:Kinetics; D008190:Lyases / Q000097:blood* / Q000302:isolation & purification; D008297:Male; D010375:Pedigree; D011162:Porphobilinogen; D011164:Porphyrias / Q000097:blood / Q000175:diagnosis / Q000201:enzymology*; D011166:Porphyrins / Q000096:biosynthesis; D013050:Spectrometry, Fluorescence
D011166:Porphyrins; D011162:Porphobilinogen; D008190:Lyases